Dilraj Deol

Dilraj Deol practices at MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health.

Dilraj Deol's NPI, 1356578058, was assigned on June 19, 2009. Dilraj Deol graduated from Sri Guru Ram Das Institute of Medical Sciences & Research in 2003. Dilraj Deol holds Maryland license D74556.

Dilraj Deol's primary practice is MedStar Good Samaritan Hospital, at 5601 Loch Raven Boulevard, Baltimore, MD 21239 in Baltimore City. The practice phone is (443) 444-3902.

Dilraj Deol's primary practice is MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health. Dilraj Deol is also affiliated with MedStar Union Memorial Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dilraj Deol to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dilraj Deol practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dilraj Deol's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dilraj Deol is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dilraj Deol's licenses on file in 3 states: Maryland, South Carolina and Michigan.

Dmand AI lists cold sores or genital herpes, hiv/aids, joint or bone infection and UTI among the conditions Dilraj Deol treats.

CMS data shows 1,191 Medicare services from Dilraj Deol across 5 procedure codes in 2024, for 552 Medicare patients. Medicare paid $113,971 for them.

CMS counts 552 Medicare patients who saw Dilraj Deol in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 3.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dilraj Deol's median patient age at 65, with 44% women.

In 2024, Dilraj Deol wrote 614 Medicare Part D claims for 98 patients. 20% of them were for generic drugs. CMS names the drug for 507 of them, across 12 drugs with 11 or more claims each, at $1,923,572 in total drug cost. In 2023, CMS named 460 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dilraj Deol for performance year 2024, reported as part of a group. Dilraj Deol accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dilraj Deol in 2021. Dilraj Deol's most frequent co-authors are Anayansi L. Lasso-Pirot, MD and Kathryn Sarah Robinett, MD.

CMS Open Payments shows 110 general payments to Dilraj Deol from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Gilead Sciences, Inc. paid the most, $6,082.

Dilraj Deol graduated from Sri Guru Ram Das Institute of Medical Sciences & Research in 2003.

Dilraj Deol is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.